{{Rsnum
|rsid=11705701
|Gene=IGF2BP2
|Chromosome=3
|position=185826521
|Orientation=plus
|GMAF=0.4642
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=IGF2BP2
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 16.8 | 55.8 | 27.4
| HCB | 3.7 | 41.5 | 54.8
| JPT | 8.8 | 43.4 | 47.8
| YRI | 80.3 | 18.4 | 1.4
| ASW | 57.1 | 37.5 | 5.4
| CHB | 3.7 | 41.5 | 54.8
| CHD | 7.3 | 33.0 | 59.6
| GIH | 26.0 | 52.0 | 22.0
| LWK | 77.3 | 20.0 | 2.7
| MEX | 5.2 | 43.1 | 51.7
| MKK | 67.3 | 29.5 | 3.2
| TSI | 25.5 | 36.3 | 38.2
| HapMapRevision=28
}}
{{PMID|19148120}} [[type-2 diabetes]], insulin sensitivity, and [[obesity]] with body fat decreasing ~1.5-2% per copy of the A allele

{{PMID Auto
|PMID=23403707
|Title=The rs11705701 G&gt;A Polymorphism of IGF2BP2 is Associated With IGF2BP2 mRNA and Protein Levels in the Visceral Adipose Tissue - A Link to Type 2 Diabetes Susceptibility
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}